Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib.

Haematologica · 2017 · PMC5541871 · PMID 28522574

Europe PMC DOI

hedged sentence

0.0313

closest p · 0.6× alpha

0.0313

boldest claim

The sentences

a clear trendP =0.0313actually significant

We also measured a clear trend of pAbl Y245 downregulation in the CD34 + CD38 − population as a function of TKI-therapy (simple Wilcoxon test after 7 days of TKI P =0.0313).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.